Insights
From stratospheric antennas to implantable bio-sensors, from the thermodynamics of carbon capture to quantum technology and AI-designed biology, we use deep tech to challenge and change the status quo.
Read our latest research and insights to help you see beyond the innovation hype and find out how emerging technologies are solving important business problems.
Digital service innovation for quantum cloud computing
What is quantum computing? That’s a question still being asked by much of the world’s C-suite. But here at CC our multidisciplinary teams of physicists, engineers and designers are already helping to plot a credible pathway for a future powered ...
Quantum computing for pharma and life sciences
What can quantum computing and quantum technology do for the pharma and life sciences industry? Elizabeth Thomas has conferred with Cambridge Consultants’ quantum experts and shares her insights into how organisations can start implementing an action plan ...
Desirability, Viability, Feasibility
Not everyone knows how to embark on the road to a new market breakthrough – or has the confidence to overcome natural hesitancy. At CC, we believe in the design thinking approach known as DVF (Desirability, Viability, Feasibility) ...
What next for precision medicine?
The world of DNA testing is changing fast and the race is on to provide cheap, quick genetic diagnoses for patients. Symon Cotton, Head of Life Sciences takes a look at the opportunities on offer for companies working in this ...
Collaboration can unlock a successful connected future for global pharma
Global pharma is hitting a major fork in the road, and one way leads to failure. For me, it’s vital that the industry comes together to grasp the once-in-a-generation opportunity that emergent technology is offering ...
Start-up technology risk management in The Engine venture ecosystem
Founders of early-stage start-ups are passionate, driven and optimistic. So, as they embark on the mission to sell their vision, they should accentuate the positive and keep negative thoughts of risk to the back of their mind, right? Wrong ...
Champions of Cell and Gene Therapy – The Medicine Maker
How do we ensure that not only the rich benefit from cell and gene therapy? Rob Collison of Cambridge Consultants says: It’s about more than cutting costs ...
Digital biomarkers for patient-empowering connected health
The future promises a digitally connected healthcare system that empowers both patients and carers alike. So, what’s the next step for pharma companies and device developers with ambitions in the space? ...
In vitro diagnostics needs seismic change to improve patient outcomes and deliver economic benefits – Technology Network
The current state of in vitro diagnostics is no longer fit for purpose. Inadequate procedures mean that critical insights are often missed, while expenditure statistics on both sides of the Atlantic reveal lagging levels of investment ...
